AAP Issues Its Own Recommended Childhood Vaccine Schedule

The American Academy of Pediatrics (AAP) has released its own recommended childhood vaccine guidance, breaking with updated recommendations issued earlier this month by the U.S. Centers for Disease Control and Prevention (CDC).¹

On Jan. 6, 2026, the CDC formally updated the U.S. childhood vaccination schedule, introducing changes as to how vaccines are categorized and recommended. While no childhod vaccines were removed from the market, the revised framework marked a significant departure from the CDC’s long-standing approach to “one-size-fits-all” universal use recommendations.²

Under the updated schedule, the number of diseases for which vaccination is recommended for all children was reduced from 17 to 11. Rather than presenting a single universal use vaccine schedule applied to almost all infants and children, the CDC reorganized childhood vaccines into three distinct categories:

• Vaccines CDC recommends for all children, including those for diphtheria, tetanus, pertussis (whooping cough) in the combination DTaP or Tdap shot; Haemophilus influenzae type b (Hib); pneumococcal; polio, measles, mumps, rubella in the combination MMR shot; varicella zoster (chickenpox), and human papillomavirus (HPV).
• Vaccines CDC recommends for certain high-risk groups, such as respiratory syncytial virus (RSV); hepatitis A; hepatitis B; and meningococcal ACWY and B, depending on individual risk factors.
• Vaccines CDC recommends be subject to “shared clinical decision-making,” including rotavirus, seasonal influenza, and COVID-19, which are now presented as options to be discussed with patients and between parents and health care providers rather than universally recommended.²

According to the CDC, the revised schedule reflects a review of scientific evidence and international practices, with the goal of improving clarity and public confidence by aligning U.S. guidance more closely with peer nations that recommend fewer vaccines universally. CDC officials concluded that the United States is a “high outlier” with regard to the high number of routine childhood vaccines administered compared to other developed countries.^{2 3}

New AAP Guidance “Basically Old CDC Vaccine Guidance”

The AAP quickly rejected the CDC’s revised approach, calling the changes “dangerous and unnecessary,” and issuing its own childhood vaccine guidance that continues to recommend immunization against 18 diseases, including RSV, hepatitis A, hepatitis B, rotavirus, influenza, and meningococcal disease—vaccines the CDC now places outside the “universally recommended” category. “The AAP will continue to provide recommendations for immunizations that are rooted in science and are in the best interest of the health of infants, children and adolescents of this country,” AAP President Andrew Racine said in a statement.¹

Amanda Kravitz, MD, a pediatrician at New York’s Weill Cornell Medicine, told CBS Evening News that the medical trade organization is “still recommending all of the vaccines that we have been recommending for many, many years,” adding that “there are no changes to the old vaccine schedule based on what the AAP is currently recommending.”¹

Céline Gounder, MD, CBS News medical contributor and editor‑at‑large for public health at KFF Health News, described the divergence as unprecedented, noting that the AAP and CDC have been “working in concert for decades.” She characterized the AAP’s guidance as effectively preserving the pre‑2026 CDC framework, stating, “The new AAP vaccine guidance is basically the old CDC vaccine guidance.”¹

CDC and HHS Defend Updated Vaccine Recommendations

U.S. government health officials pushed back on claims that the CDC’s revisions reduce vaccine access or protection. In a Jan. 5, 2026 statement, the U.S. Department of Health and Human Services (DHHS) said the updated schedule “continues to protect children against serious diseases while aligning U.S. guidance with international norms,” and pledged to work with states and clinicians to ensure families receive “clear, accurate information” to support informed decision‑making.⁴

Secretary of Health and Human Services Robert F. Kennedy, Jr. framed the changes as part of a broader effort to rebuild trust in public health institutions. He said:

President Trump directed us to examine how other developed nations protect their children and to take action if they are doing better. After an exhaustive review of the evidence, we are aligning the U.S. childhood vaccine schedule with international consensus while strengthening transparency and informed consent. This decision protects children, respects families, and rebuilds trust in public health.^{4 5}

In a separate interview with CBS News chief White House correspondent Nancy Cordes, Kennedy stressed that the updated schedule does not restrict access. “We’re not taking vaccines away from anybody,” he said. “If you want to get the vaccine, you can get it. It’s going to be fully covered by insurance, just like it was before.¹

AAP Has Significant Financial Ties to Pharmaceutical Companies

The AAP publicly lists numerous pharmaceutical manufacturers as “current partners,” including several drug manufacturers that produce childhood vaccines. According to the organization’s disclosures, many of these companies participate in the AAP’s highest sponsorship tier, referred to as the “President’s Circle,” which involves annual contributions exceeding $50,000.⁶

The AAP states that such funding supports educational initiatives and operational costs, and that corporate partners do not influence clinical guidance or policy decisions. Still, the scale of vaccine industry support raises concerns about whether organizational financial relationships warrant closer scrutiny—particularly as the medical trade group pushes to preserve older vaccine recommendations that include significantly more vaccines and, by extension, greater commercial stakes for vaccine manufacturers.⁶

AAP Named in Federal RICO Lawsuit

The AAP’s divergence from the CDC’s updated vaccine guidance comes as a federal lawsuit by Children’s Health Defense (CHD) filed against the organization alleges violations under the Racketeer Influenced and Corrupt Organizations (RICO) Act. The lawsuit asserts that the AAP engaged in a coordinated pattern of misconduct related to vaccine safety messaging and advocacy.⁷

Epidemiologist Nicolas Hulscher, MPH commenting on the lawsuit in a Substack post, characterized the filing as “not another ‘vaccine debate’ lawsuit,” but rather “a RICO fraud case—the same legal framework historically used against organized crime and the tobacco industry.”

The AAP has not responded to the allegations, and the claims have not yet been heard in court.⁷

If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.